Anders Gilberg, senior vice president for government affairs at MGMA, discusses how the organization looks to approach some of the personalities being named to lead roles at HHS.
As Congress acts quickly to enact President Donald J. Trump's agenda, his Agency appointees are working their way through the confirmation process.
While this group of outsiders might seem daunting to casual observers some organizations are looking for common ground.
Anders Gilberg, senior vice president for government affairs at MGMA, discusses how the organization looks to approach some of the personalities being named to lead roles at HHS.
Transcript:
Anders Gilberg: Yeah. I mean it's quite, an interesting kind of, coalition of leaders that President Trump has put together. I only know, RFK from other health care issues, not necessarily the issues we focus on specifically. also, Doctor Oz, I know a little bit about his positions politically when he ran for office and Senate, the United States Senate in Pennsylvania. But, you know, in many ways there are unknown quantities as it relates specifically to, you know, non-FDA kind of the more controversial things that are often focused on with respect to RFK and the issues we focus on more, more readily, which would be reimbursement issues.
Deregulation, which I think fits nicely within this, the purview of this administration and, other ways to get the red tape out of delivering health care in this country and ways to make sure that medical groups still have that ability to operate independently if they wish to. So some of those issues are not not as well known. And, but that we'll spend some time over the next few months, working to establish these relationships. And I feel like, we'll have a sympathetic ear, especially on the deregulation side.